[go: up one dir, main page]

ATE373005T1 - Thienopyrrole als antivirale mittel - Google Patents

Thienopyrrole als antivirale mittel

Info

Publication number
ATE373005T1
ATE373005T1 AT04768385T AT04768385T ATE373005T1 AT E373005 T1 ATE373005 T1 AT E373005T1 AT 04768385 T AT04768385 T AT 04768385T AT 04768385 T AT04768385 T AT 04768385T AT E373005 T1 ATE373005 T1 AT E373005T1
Authority
AT
Austria
Prior art keywords
thienopyrroles
antiviral agents
hepatitis
infections
prevention
Prior art date
Application number
AT04768385T
Other languages
English (en)
Inventor
Barbara Attenni
Jose Ignacio Martin Hernando
Savina Malancona
Frank Narjes
Ontoria Jesus Maria Ontoria
Michael Rowley
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Application granted granted Critical
Publication of ATE373005T1 publication Critical patent/ATE373005T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
AT04768385T 2003-09-09 2004-09-07 Thienopyrrole als antivirale mittel ATE373005T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0321003.6A GB0321003D0 (en) 2003-09-09 2003-09-09 Compounds, compositions and uses

Publications (1)

Publication Number Publication Date
ATE373005T1 true ATE373005T1 (de) 2007-09-15

Family

ID=29226699

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04768385T ATE373005T1 (de) 2003-09-09 2004-09-07 Thienopyrrole als antivirale mittel

Country Status (11)

Country Link
US (1) US7781431B2 (de)
EP (1) EP1664059B1 (de)
JP (1) JP2007505091A (de)
CN (1) CN1849323A (de)
AT (1) ATE373005T1 (de)
AU (1) AU2004270470A1 (de)
CA (1) CA2537545A1 (de)
DE (1) DE602004008945T2 (de)
ES (1) ES2291933T3 (de)
GB (1) GB0321003D0 (de)
WO (1) WO2005023819A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200517381A (en) 2003-08-01 2005-06-01 Genelabs Tech Inc Bicyclic heteroaryl derivatives
EP1688420A4 (de) * 2003-11-19 2008-10-22 Japan Tobacco Inc 5-5-gliedrige kondensierte heterocyclische verbindung und deren verwendung als hcv-polymeraseinhibitor
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
GB0416396D0 (en) * 2004-07-22 2004-08-25 Angeletti P Ist Richerche Bio Therapeutic agents
US7659263B2 (en) * 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
AU2006242475B2 (en) 2005-05-02 2011-07-07 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
GB0509326D0 (en) * 2005-05-09 2005-06-15 Angeletti P Ist Richerche Bio Therapeutic compounds
RU2008107972A (ru) 2005-08-01 2009-09-10 Мерк энд Ко., Инк. (US) Макроциклические пептиды в качестве ингибиторов ns3-протеазы hcv
GB0609492D0 (en) 2006-05-15 2006-06-21 Angeletti P Ist Richerche Bio Therapeutic agents
GB0612423D0 (en) 2006-06-23 2006-08-02 Angeletti P Ist Richerche Bio Therapeutic agents
AU2007309546A1 (en) 2006-10-24 2008-05-02 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. HCV NS3 protease inhibitors
US8138164B2 (en) 2006-10-24 2012-03-20 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
US8309540B2 (en) 2006-10-24 2012-11-13 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
EP2083844B1 (de) 2006-10-27 2013-11-27 Merck Sharp & Dohme Corp. Inhibitoren der hcv-ns3-protease
EP2086982B1 (de) 2006-10-27 2018-08-29 Merck Sharp & Dohme Corp. Hcv-ns3-protease-hemmer
CN103224506A (zh) 2006-12-20 2013-07-31 P.安杰莱蒂分子生物学研究所 抗病毒的吲哚
GB0625345D0 (en) 2006-12-20 2007-01-31 Angeletti P Ist Richerche Bio Therapeutic compounds
GB0625349D0 (en) 2006-12-20 2007-01-31 Angeletti P Ist Richerche Bio Therapeutic compounds
AU2008277442A1 (en) 2007-07-17 2009-01-22 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Macrocyclic indole derivatives for the treatment of hepatitis C infections
WO2009010804A1 (en) 2007-07-19 2009-01-22 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Macrocyclic compounds as antiviral agents
MX2010006313A (es) 2007-12-19 2010-06-25 Boehringer Ingelheim Int Inhibidores de la polimerasa virica.
CA2720850A1 (en) 2008-04-28 2009-11-05 Merck Sharp & Dohme Corp. Hcv ns3 protease inhibitors
US8126839B2 (en) * 2008-06-19 2012-02-28 Yahoo! Inc. Methods and apparatuses for adapting a ranking function of a search engine for use with a specific domain
PL2310095T3 (pl) 2008-07-22 2013-03-29 Msd Italia Srl Makrocykliczne związki chinoksaliny jako inhibitory proteazy NS3 HCV
JP2012514605A (ja) 2009-01-07 2012-06-28 サイネクシス，インコーポレーテッド Ｈｃｖおよびｈｉｖ感染の治療への使用におけるシクロスポリン誘導体
WO2011014487A1 (en) 2009-07-30 2011-02-03 Merck Sharp & Dohme Corp. Hepatitis c virus ns3 protease inhibitors
TW201130852A (en) * 2009-12-23 2011-09-16 Abbott Lab Novel thienopyrrole compounds
CN105399697A (zh) * 2014-09-12 2016-03-16 苏州旺山旺水生物医药有限公司 一种氨基磺酰基类化合物、其制备方法及用途
EP3246330A1 (de) * 2016-05-18 2017-11-22 Istituto Europeo di Oncologia S.r.l. Imidazoles als histone demethylase inhibitoren
MY200452A (en) * 2018-08-21 2023-12-27 Kyorin Seiyaku Kk Bicyclic heteroaromatic ring derivative

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3706810A (en) * 1970-09-15 1972-12-19 American Cyanamid Co N-morpholinoalkyl-thieno(3,2-b)pyrrole-5-carboxamides
SU367098A1 (ru) * 1971-01-20 1973-01-23 Способ получения производных 4,5-диоксотиено- -
SU478833A1 (ru) * 1972-12-29 1975-07-30 Всесоюзный Научно-Исследовательский Химико-Фармацевтический Институт Им.С.Орджоникидзе Способ получени производных тиено -(3,2-в)-пиррола
JPH04356029A (ja) 1990-07-02 1992-12-09 Japan Synthetic Rubber Co Ltd 非線形光学素子
JPH04179949A (ja) * 1990-11-15 1992-06-26 Fuji Photo Film Co Ltd 新規な色素形成カプラーおよび該カプラーを用いたハロゲン化銀カラー写真感光材料
US5340833A (en) * 1992-05-01 1994-08-23 Eisai Co., Ltd. Urokinase inhibitors
NZ514403A (en) 1999-12-27 2002-10-25 Japan Tobacco Inc Fused-ring compounds and use thereof as drugs
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
AR035543A1 (es) 2001-06-26 2004-06-16 Japan Tobacco Inc Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
JP2003212846A (ja) * 2001-06-26 2003-07-30 Japan Tobacco Inc 縮合環化合物及びｃ型肝炎治療剤
CA2448737C (en) 2001-07-20 2010-06-01 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
EP2335700A1 (de) * 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C Virus Polymerase Inhibitoren mit heterobicylischer Struktur
US20030134853A1 (en) 2001-09-26 2003-07-17 Priestley Eldon Scott Compounds useful for treating hepatitis C virus
GB0222909D0 (en) * 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
EP1620427A1 (de) * 2003-04-17 2006-02-01 Pfizer Products Inc. Carbonsäureamid-derivate als antidiabetika

Also Published As

Publication number Publication date
JP2007505091A (ja) 2007-03-08
DE602004008945T2 (de) 2008-05-29
WO2005023819A9 (en) 2006-03-23
AU2004270470A1 (en) 2005-03-17
WO2005023819A1 (en) 2005-03-17
CN1849323A (zh) 2006-10-18
EP1664059B1 (de) 2007-09-12
GB0321003D0 (en) 2003-10-08
CA2537545A1 (en) 2005-03-17
ES2291933T3 (es) 2008-03-01
US7781431B2 (en) 2010-08-24
EP1664059A1 (de) 2006-06-07
US20090036443A1 (en) 2009-02-05
DE602004008945D1 (en) 2007-10-25

Similar Documents

Publication Publication Date Title
ATE373005T1 (de) Thienopyrrole als antivirale mittel
DE602005023015D1 (de) Indolderivate als viruzide
NZ609146A (en) Modified 4’-nucleosides as antiviral agents
MX2007004979A (es) Derivados de indol tetraciclicos como agentes antiviricos.
WO2006027628A3 (en) Naphthalimide derivatives as antiviral agents
PL1802650T3 (pl) 3-Etero i 3-tioetero podstawione pochodne cyklosporyny do leczenia i zapobiegania zakażeniu wirusem zapalenia wątroby typu C
AP1753A (en) Thiophene derivatives as antiviral agents for flavvivirus infection
DOP2002000456A (es) Inhibidores de la alquin-aril fosfodiesterasa-4''
CY1110835T1 (el) Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c
ATE466856T1 (de) Verbindungen und methoden zum behandeln oder vorbeugen von flavivirus infektionen
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
EA200401436A1 (ru) Ингибиторы протеазы вич для лечения инфекции вич и фармацевтическая композиция
ECSP056181A (es) Compuestos Inhibidores de la Hepatitis C
WO2007029029A3 (en) Tetracyclic indole derivatives as antiviral agents
NO20060973L (no) Pyridylderivater og deres anvendelse som tempeutiske midler
DE60236102D1 (en) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
ATE526341T1 (de) Makrozyklische verbindungen als antivirale mittel
CY1110690T1 (el) Ενωσεις 4-οξοκινολινης και χρησιμοποιηση αυτων ως αναστολεις της ενσωματασης του hiv
NO20052787D0 (no) N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
MXPA06000418A (es) Derivados de ariltiourea sustituida utiles como inhibidores de duplicacion viral.
ATE368645T1 (de) Aminosäurederivate als hiv-protease-inhibitoren
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
WO2004037784A3 (en) Pyrrolidones with anti-hiv activity
MXPA04006041A (es) Antivirales de piridoquinoxalina.
NO20074167L (no) Peptidiske forbindelser

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties